Tiansheng Pharmaceutical Group Co Ltd (002872) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.011x

Based on the latest financial reports, Tiansheng Pharmaceutical Group Co Ltd (002872) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-22.57 Million ≈ $-3.30 Million USD) by net assets (CN¥1.97 Billion ≈ $288.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002872 net asset quality index to measure how much of total assets are equity-financed.

Tiansheng Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Tiansheng Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Tiansheng Pharmaceutical Group Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Tiansheng Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tiansheng Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fujian Sanmu Group Co Ltd SHE:000632	-0.347x
Otovo AS OL:OTOVO	-0.387x
Richmond Mutual Bancorporation Inc NASDAQ:RMBI	0.019x
Panca Budi Idaman Tbk PT JK:PBID	0.019x
Groupe Pizzorno Environnement SA PA:GPE	0.332x
Vakko Tekstil ve Hazir Giyim Sanayi Isletmeleri AS IS:VAKKO	0.107x
Jasuindo Tiga Perkasa Tbk JK:JTPE	-0.046x
Virginia National Bankshares Corp NASDAQ:VABK	0.035x

Annual Cash Flow Conversion Efficiency for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 002872 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.01 Billion ≈ $294.76 Million	CN¥50.15 Million ≈ $7.34 Million	0.025x	+312.41%
2023-12-31	CN¥2.10 Billion ≈ $306.66 Million	CN¥-24.56 Million ≈ $-3.59 Million	-0.012x	-128.75%
2022-12-31	CN¥2.19 Billion ≈ $320.11 Million	CN¥89.18 Million ≈ $13.05 Million	0.041x	+389.79%
2021-12-31	CN¥2.28 Billion ≈ $333.52 Million	CN¥18.97 Million ≈ $2.78 Million	0.008x	-89.52%
2020-12-31	CN¥2.39 Billion ≈ $349.69 Million	CN¥189.75 Million ≈ $27.77 Million	0.079x	+62.67%
2019-12-31	CN¥2.95 Billion ≈ $432.30 Million	CN¥144.21 Million ≈ $21.10 Million	0.049x	+0.86%
2018-12-31	CN¥3.18 Billion ≈ $465.60 Million	CN¥153.99 Million ≈ $22.53 Million	0.048x	+376.86%
2017-12-31	CN¥3.19 Billion ≈ $466.69 Million	CN¥-55.75 Million ≈ $-8.16 Million	-0.017x	-106.41%
2016-12-31	CN¥1.86 Billion ≈ $272.02 Million	CN¥506.68 Million ≈ $74.14 Million	0.273x	+107.92%
2015-12-31	CN¥1.63 Billion ≈ $238.37 Million	CN¥213.54 Million ≈ $31.25 Million	0.131x	-2.29%
2014-12-31	CN¥1.43 Billion ≈ $209.40 Million	CN¥191.99 Million ≈ $28.09 Million	0.134x	+153.41%
2013-12-31	CN¥1.08 Billion ≈ $157.71 Million	CN¥57.06 Million ≈ $8.35 Million	0.053x	-65.27%
2012-12-31	CN¥951.66 Million ≈ $139.26 Million	CN¥145.06 Million ≈ $21.23 Million	0.152x	--

About Tiansheng Pharmaceutical Group Co Ltd

SHE:002872 China Biotechnology

Market Cap

$234.99 Million

CN¥1.61 Billion CNY

Market Cap Rank

#15894 Global

#4599 in China

Share Price

CN¥5.05

Change (1 day)

+2.02%

52-Week Range

CN¥4.47 - CN¥5.70

All Time High

CN¥32.59